文献速递心律失常

肥胖房颤患者双组电极片与单组电极片电复律的随机临床试验

Dual vs Single Cardioversion of Atrial Fibrillation in Patients With Obesity: A Randomized Clinical Trial.
PubMed 文献 · JAMA Cardiol · 2024-01-01

该多中心随机临床试验纳入BMI≥35的房颤患者,比较双组电极片(每组同时释放200J)与单组200J电复律的疗效与安全性。

要点

  • 对于BMI≥35的房颤患者,双组电极片电复律一次成功率显著高于单组(98% vs 86%)。
  • 单组首次失败后改用双组电极片复律,后续尝试均成功(14例中12例第二次成功,2例第三次成功)。

核心结论

  • 在BMI≥35的肥胖房颤患者中,双组电极片电复律较单组200J电复律成功率更高,且不增加并发症或患者不适。

研究设计与样本

  • 前瞻性、研究者发起、患者盲法、随机临床试验,为期3年(2020年8月至2023年),在路易斯安那州3个中心进行。
  • 纳入标准:BMI≥35、年龄≥18岁、计划非急诊电复律的房颤患者;共276例符合条件,210例随机1:1,最终200例完成研究(中位年龄67.6岁,男性127例占63.5%,平均BMI 41.2)。

主要发现

  • 单组首次失败后改用双组复律,14例中12例第二次成功、2例第三次成功。

临床怎么用

  • 对于BMI≥35的肥胖房颤患者,可考虑首选双组电极片电复律以提高一次成功率。
  • 单组电极片首次复律失败后,改用双组电极片再次尝试仍可成功。

局限性

  • 研究仅纳入BMI≥35的患者,结论不能外推至BMI<35人群。
  • 研究在路易斯安那州3个中心进行,可能存在地域局限性。
  • 样本量较小(最终200例完成研究)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Atrial fibrillation and obesity are common, and both are increasing in prevalence. Obesity is associated with failure of cardioversion of atrial fibrillation using a standard single set of defibrillator pads, even at high output. OBJECTIVE: To compare the efficacy and safety of dual direct-current cardioversion (DCCV) using 2 sets of pads, with each pair simultaneously delivering 200 J, with traditional single 200-J DCCV using 1 set of pads in patients with obesity and atrial fibrillation. DESIGN, SETTING, AND PARTICIPANTS: This was a prospective, investigator-initiated, patient-blinded, randomized clinical trial spanning 3 years from August 2020 to 2023. As a multicenter trial, the setting included 3 sites in Louisiana. Eligibility criteria included body mass index (BMI) of 35 or higher (calculated as weight in kilograms divided by height in meters squared), age 18 years or older, and planned nonemergent electrical cardioversion for atrial fibrillation. Patients who met inclusion criteria were randomized 1:1. Exclusions occurred due to spontaneous cardioversion, instability, thrombus, or BMI below threshold. INTERVENTIONS: Dual DCCV vs single DCCV. MAIN OUTCOMES AND MEASURES: Return to sinus rhythm, regardless of duration, immediately after the first cardioversion attempt of atrial fibrillation, adverse cardiovascular events, and chest discomfort after the procedure. RESULTS: Of 2079 sequential patients undergoing cardioversion, 276 met inclusion criteria and were approached for participation. Of these, 210 participants were randomized 1:1. After exclusions, 200 patients (median [IQR] age, 67.6 [60.1-72.4] years; 127 male [63.5%]) completed the study. The mean (SD) BMI was 41.2 (6.5). Cardioversion was successful more often with dual DCCV compared with single DCCV (97 of 99 patients [98%] vs 87 of 101 patients [86%]; P = .002). Dual cardioversion predicted success (odds ratio, 6.7; 95% CI, 3.3-13.6; P = .01). Patients in the single cardioversion cohort whose first attempt failed underwent dual cardioversion with all subsequent attempts (up to 3 total), all of which were successful: 12 of 14 after second cardioversion and 2 of 14 after third cardioversion. There was no difference in the rating of postprocedure chest discomfort (median in both groups = 0 of 10; P = .40). There were no cardiovascular complications. CONCLUSIONS AND RELEVANCE: In patients with obesity (BMI ≥35) undergoing electrical cardioversion for atrial fibrillation, dual DCCV results in greater cardioversion success compared with single DCCV, without any increase in complications or patient discomfort. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04539158.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Aymond JD, Sanchez AM, Castine MR, et al. Dual vs Single Cardioversion of Atrial Fibrillation in Patients With Obesity: A Randomized Clinical Trial. JAMA Cardiol. 2024. PMID: 38776097. doi:10.1001/jamacardio.2024.1091

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。